The latest price target for Sophia Genetics (NASDAQ:SOPH) was reported by Guggenheim on January 26, 2026. The analyst firm set a price target for $7.00 expecting SOPH to rise to within 12 months (a possible 40.00% upside). 2 analyst firms have reported ratings in the last year.

The latest analyst rating for Sophia Genetics (NASDAQ:SOPH) was provided by Guggenheim, and Sophia Genetics maintained their buy rating.

There is no last upgrade for Sophia Genetics

There is no last downgrade for Sophia Genetics.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sophia Genetics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sophia Genetics was filed on January 26, 2026 so you should expect the next rating to be made available sometime around January 26, 2027.

While ratings are subjective and will change, the latest Sophia Genetics (SOPH) rating was a maintained with a price target of $6.00 to $7.00. The current price Sophia Genetics (SOPH) is trading at is $5.00, which is out of the analyst’s predicted range.